From: Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis
Metoclopramide | Â | Â | Â | Â | Â | Â |
1.32 (0.27–6.06) | Trimebutine |  |  |  |  |  |
1.99 (0.87–4.72) | 1.51 (0.38–6.74) | Mosapride |  |  |  |  |
2.04 (0.92–4.60) | 1.54 (0.40–6.73) | 1.02 (0.64–1.65) | Domperidone |  |  |  |
2.79 (1.29–6.21) | 2.12 (0.56–9.05) | 1.40 (0.92–2.14) | 1.37 (1.07–1.77) | Itopride |  |  |
3.07 (1.43–6.75) | 2.32 (0.61–9.86) | 1.53 (0.97–2.45) | 1.51 (1.04–2.18) | 1.10 (0.80–1.51) | Itopride |  |
6.27 (3.03–13.48) | 4.77 (1.27–19.99) | 3.15 (2.09–4.74) | 3.15 (2.09–4.74) | 2.25 (1.78–2.85) | 2.05 (1.65–2.55) | Placebo |